APA (7th ed.) Citation

Farias, A., Soto, A., Puttur, F., Goldin, C. J., Sosa, S., Gil, C., . . . Berguer, P. M. (2021). A TLR4 agonist improves immune checkpoint blockade treatment by increasing the ratio of effector to regulatory cells within the tumor microenvironment. Nature Portfolio.

Chicago Style (17th ed.) Citation

Farias, A., A. Soto, F. Puttur, C. J. Goldin, S. Sosa, C. Gil, F. A. Goldbaum, and P. M. Berguer. A TLR4 Agonist Improves Immune Checkpoint Blockade Treatment by Increasing the Ratio of Effector to Regulatory Cells Within the Tumor Microenvironment. Nature Portfolio, 2021.

MLA (8th ed.) Citation

Farias, A., et al. A TLR4 Agonist Improves Immune Checkpoint Blockade Treatment by Increasing the Ratio of Effector to Regulatory Cells Within the Tumor Microenvironment. Nature Portfolio, 2021.